Parkinson`S Disease Product Applications

Over 50 million people globally are impacted by dementia. 25% of those over age 55 have a family history of dementia.* Tesis Labs Parkinson-Alzheimer-Dementia Panel examines 35 genes associated with an increased risk of developing neurodegenerative conditions: Parkinson’s disease, Alzheimer’s disease, Genetic disorders that cause ...

By Tesis Biosciences based in Scottsdale, ARIZONA (USA).

More than 5 million people in the United States and an estimated 50 million people worldwide are living with Alzheimer’s disease. More than 10 million people worldwide are living with Parkinson’s. ...

By Base Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA).

Deep brain stimulation (DBS) is a therapeutic approach that involves implanting electrodes in precise brain areas and fine-tuning the stimulation to alleviate symptoms such as in Parkinson’s disease. The variance in patient outcomes post-DBS is often linked to the optimization of DBS programming, which is inherently complex due to the multitude of adjustable parameters like contact points, polarity, frequency, pulse width, and amplitude. ...

By Great Lakes NeuroTechnologies based in Cleveland, OHIO (USA).

Stroke upper limb rehabilitation with Axinesis: If you have a neurological condition, rehabilitation should help you achieve optimal outcomes while being safe and engaging. Axinesis’s neurorehabilitation devices support effective upper extremity rehabilitation in conditions such as stroke, Parkinson’s disease, cerebral palsy and multiple ...

By Axinesis based in Wavre, BELGIUM.

Neurological impairments such as strokes, spinal cord injuries, traumatic brain injuries, cerebral palsy, multiple sclerosis, and Parkinson’s disease can significantly affect a patient’s mobility, and many patients affected with these conditions have a significant long-term mobility impairment. ...

By Techno Concept based in Manosque, FRANCE.

As targeted therapies evolve and the limitations of antibody-based therapies become clearer, a growing number of research teams are exploring the therapeutic potential of ...

By Base Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA).

Assistive rehabilitation technology for your hospital, clinic or therapy centre: Axinesis’s cost-effective and clinically proven neurorehabilitation devices help optimize patient outcomes while simplifying your workflows and maximizing therapy time. ...

By Axinesis based in Wavre, BELGIUM.

BOC Sciences is committed to supplying cost-effective products and services. We provide Pimavanserin (Cas No:706779-91-1). More information, please visit the website: http://www.bocsci.com/pimavanserin-cas-706779-91-1-item-75664.html ...

By BOC Sciences based in Shirley, NEW YORK (USA).